Follow Us
Blog Categories
- American Stem Cell Therapy Association (46)
- Cardiac Applications (2)
- Case Reports (40)
- Cervical (3)
- Centeno-Schultz Blog (117)
- Conditions and Treatment Options for the Spine (55)
- Cervical Spine (24)
- Lumbar Spine (42)
- Sacral Spine (6)
- Thoracic Spine (1)
- FDA Regulation (11)
- Hip (23)
- International Cellular Medicine Society (63)
- Knee Posts (4)
- Latest News (5)
- Lower Extremity (54)
- Medication Interactions (7)
- Nerve Posts (1)
- Patient Case Studies (14)
- Back Pain (3)
- Buttocks Pain (2)
- Headaches / Neck Pain (3)
- Hip Pain (1)
- Knee Pain (2)
- Pelvic Pain (1)
- Shoulder & Rotator Cuff (1)
- Thoracic Pain (4)
- Procedures (1)
- PRP (4)
- PSTIM (1)
- Recent Press (6)
- Regenerative (2)
- Regenexx-PL Disc (2)
- Regenexx-SCP (2)
- Regenexx-SD (1)
- Uncategorized (132)
- Stem Cell Basics (43)
- Upper Extremity (39)
- Home
- About
- Services
- C-Arm Fluoroscopy
- Disc Procedures
- Epidural Injections
- Postural Restoration
- Facet Injections
- Intramuscular Stimulation
- MSK Ultrasound
- Multi-Cervical Unit
- Nerve Hydrodissection
- PL/Dex Injections
- Prolotherapy
- PRP – Platelet Rich Plasma
- Pulsed Radiofrequency
- Regenexx Procedures
- SI Joint Injections
- Trigger Point Injections
- Case Studies
- Patient Info
- Contact Us
- Blog
: Tag / FDA regulation of adult
Centeno Schultz Clinic » Posts tagged 'FDA regulation of adult'
Age Management Medicine Enters Stem Cell Therapy Discussion
Posted by: John R. Schultz M.D.
Tags:
Adult stem cells, FDA regulation of adult, Regenexx
Posted date:
April 22, 2009 |
No comment
The adult stem cell debate about the FDA trying to classify the patient's stem cells as drugs is heating up. Interesting article this morning from a physician proferssional organization on Regenexx, the FDA, and Adult Stem Cell Clinical and Lab Guidelines. I think the article says it all. Age management is a new field that many doctors have embraced. This AMMG professional group recognizes that...
Read More
Adult Stems Cells Improve Heart Function
Posted by: John R. Schultz M.D.
Tags:
Adult, autologous stem cell therapy for cardiac infarction, FDA regulation of adult, FDA's attempt to control expansion of adult, FDA's opinion that minimal cell expansion constitutes manafacture of drug, Improved cardiac blood flow with infusion of stem cells
Posted date:
April 5, 2009 |
No comment
Two items had major headlines this week: adult stem cell therapy for cardiac patients and the snow in Vail. Two recent storms have brought record amounts of snow to Vail. Words alone can not accurately describe the back bowls! Physicians at Emory University have demonstrated that infusing bone-marrow-derived, autolgous stem cells in patients who have sustained a heart attack and underwent...
Read More
Minimal Culture Expansion: A Historial Perspective
Posted by: John R. Schultz M.D.
Tags:
autologous stem cells, FDA regulation of adult, FDA's attempt to control expansion of adult, Minimal culture expansion, Practice of medicine
Posted date:
March 31, 2009 |
Comment
The evolution of In-Vitro Fertilization (IVF) illustrates the development of a minimal culture expansion process. In the late 1970's, the first IVF was performed. In the 1990's, in an effort to improve conception outcomes, fertility specialists elected to extend the cell culture time. Specifically they extended cell culture to the blastocyst stage which is a more mature developmental phase....
Read More
Expansion of Adult Stem Cells: Making A Drug?
Posted by: John R. Schultz M.D.
Tags:
Adult Stem Cell Minimal Expansion, autologous mesenchymal stem cell therapy, bone marrow aspirate concentrate machines, bone marrow aspirates, FDA regulation of adult, Stem Cell Manipulation
Posted date:
March 29, 2009 |
2 Comments
Autologous, adult mesenchymal stem cells have proven to be an effective therapy for patients who have orthopedic injuries. Specifically, autologous, adult mesenchymal stem cell therapy has regenerated cartilage in knees, hips and thumbs, repaired tendon injuries, reduced the size of protrusions in the lumbar spine and healed long bone non-union fractures. Regenexx isolates a patients own mesenchymal...
Read More
Your Own Tissue is Not Yours: It is a Drug
Posted by: John R. Schultz M.D.
Tags:
Adult, Adult stem cells, autologous mesenchymal stem cells, Autologous Stem Cells are Drugs, FDA regulation of adult, Regulation of autologous
Posted date:
March 28, 2009 |
No comment
Regenexx utilizes a patients' own stem cells to repair damaged ligaments, tendons, cartilage and bone. Regenexx exclusively uses autologous adult mesenchymal stem cells which are derived from the bone marrow of the patient being treated. The clinical successes utilizing adult autologous stem cells have been published in peer reviewed journals. Additional studies have been submitted and accepted...
Read More
Follow Us
Quick Links
Make an Appointment
The Centeno Schultz Clinic
403 Summit Blvd Suite 201
Broomfield, CO 80021
(303) 429-6448
info@centenoschultz.comTestimonials
“We did the right knee in March 2007. I was off my feet for about an hour after each of the treatments, but that was it. No long recovery time, no time off from work – it was great. The cartilage began to grow back, and the knee was feeling much better, so we did the left knee in October. Since about two weeks later, I haven’t had any pain at all in either knee for the first time in 10 years. It’s fantastic.”
— Kenvir DixonI’m back to my conditioning classes, doing squats, lunges, jumping rope and even a little bit of jogging. My knee feels, looks and works better every day. I’m definitely looking forward to the winter and getting back on my snowboard as soon as I can.
— Pixie GreenmeierFollow Us
Content copyright 2012. Centeno Schultz Clinic. All rights reserved. Site by Klein New Media